2019 US Medicinal Products

Financial Strength Rankings using Artificial Intelligence

Top rated12 of 50
Best rating268 %
Worst rating-1,391 %
New companies7
Negative Economic Capital Ratio23 of 50

FITLIFE BRANDS INC. climbed 25 positions from 38 to 13 due it’s excellent Net Income. Navidea Biopharmaceuticals Inc. lost 47 positions from 1 to 48 due it’s bad Net Income. Electronic Servitor Publication Network Inc. entered the 2019 ranking at rank 17, making it the best newcomer.

Revenues41.6 B
Assets55.1 B
Expenses38.6 B
Stockholders Equity22.6 B
Unprofitable companies28 of 50

2. NEOGEN CORP

256.73%

5. INNOSPEC INC.

176.73%

7. BALCHEM CORP

169.27%

8. HESKA CORP

166.42%

9. MARIMED INC.

150.70%

10. FMC CORP

148.02%

11. KMG CHEMICALS INC

117.91%

12. CYANOTECH CORP

116.59%

15. Ingevity Corp

93.62%

18. Chemours Co

71.75%

19. Huntsman CORP

70.47%

20. IMMUCELL CORP DE

66.59%

21. Ecovyst Inc.

56.70%

23. OLIN Corp

46.47%

24. W R GRACE & CO

32.44%

25. MANNATECH INC

17.64%

29. Tilray Brands Inc.

-10.35%

30. BIOMERICA INC

-39.67%

31. Target Group Inc.

-81.24%

33. IMMUNOMEDICS INC

-144.80%

35. Stem Holdings Inc.

-205.36%

36. GL Brands Inc.

-224.44%

40. CAT9 Group Inc.

-471.59%

43. VOLITIONRX LTD

-517.08%

45. ARCA biopharma Inc.

-671.27%

United States Ratings

German Insurance Ratings